trazodone has been researched along with Embolism in 1 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Embolism: Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allori, L | 1 |
| Cioli, V | 1 |
| Silvestrini, B | 1 |
1 trial available for trazodone and Embolism
| Article | Year |
|---|---|
Experimental and clinical data indicating a potential use of trazodone in acute stroke.
Topics: Acute Disease; Aged; Animals; Cerebrospinal Fluid; Cerebrovascular Disorders; Clinical Trials as Top | 1975 |